$5 Stock to Surge on FDA Announcement
In a matter of weeks we could see the greatest wealth opportunity of the year – and even our lives.
When the FDA ”fast-tracks” approval for a cutting-edge new cancer therapy – called ”Alpha Cells” – shares of the tiny $5 stock behind the development could surge to $12… $60… and as high as $136.
That’s good enough to turn every 10,000 into $270,000 before 2016 is over – and that’s just to start.
But you must move now. The FDA has already ”tipped its hand” that approval is all but guaranteed. Insiders at the company are loading up on shares in anticipation of approval.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.